Skip to main content
Log in

The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

The loudness dependence of the auditory evoked potential (LDAEP) has been proposed as a potential biological marker of central serotonergic activity. This study aimed to test the hypothesis that the LDAEP can be used to predict the response to escitalopram in patients with GAD.

Method

Twenty-five patients with GAD were recruited. Scores on the Hamilton Anxiety Rating Scale (HAM-A), Clinical Global Impression-Severity Scale (CGI-S), and Beck Anxiety Inventory (BAI) were evaluated. To evaluate the LDAEP, the auditory event-related potential was measured before beginning medication. Peak-to-peak N1/P2 amplitudes and current source densities were calculated at five stimulus intensities, and the LDAEP was calculated as the linear-regression slope. The current source densities of the evoked potentials were analyzed by standardized low-resolution brain electromagnetic tomography (sLORETA). The loudness dependence of the current densities (sLORETA-LDAEP) was also calculated.

Results

The pretreatment LDAEPs of all patients were positively correlated with the CGI-S response rates at 4 and 8 weeks, and with the HAM-A and BAI response rates at 8 weeks. The sLORETA-LDAEPs were positively correlated with the HAM-A response rates after 8 weeks of treatment. The HAM-A and CGI response rates at 8 weeks were higher in patients with a strong pretreatment LDAEP than in those with a weak LDAEP.

Conclusions

The present study revealed that GAD patients with a favorable response to escitalopram treatment are characterized by a stronger pretreatment LDAEP. Measurement of the LDAEP appears to provide useful clinical information for predicting treatment responses in patients with GAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, DSM-IV, 4th edn. American Psychiatric Press, Washington, DC

    Google Scholar 

  • Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, WFSBP task force on treatment guidelines for anxiety, obsessive-compulsive and post-traumatic stress disorders (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders—first revision. World J Biol Psychiatry 9:248–312

    Article  PubMed  Google Scholar 

  • Brett M, Johnsrude IS, Owen AM (2002) The problem of functional localization in the human brain. Nat Rev Neurosci 3:243–249

    Article  CAS  PubMed  Google Scholar 

  • Connor KM, Davidson JR (1998) Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. Biol Psychiatry 44:1286–1294

    Article  CAS  PubMed  Google Scholar 

  • Coric V, Stock EG, Pultz J, Marcus R, Sheehan DV (2009) Sheehan suicidality tracking scale (Sheehan-STS): preliminary results from a multicenter clinical trial in generalized anxiety disorder. Psychiatry (Edgmont) 6:26–31

    Google Scholar 

  • Davidson JR (2009) First-line pharmacotherapy approaches for generalized anxiety disorder. J Clin Psychiatry 70:25–31

    Article  CAS  PubMed  Google Scholar 

  • Fuchs M, Kastner J, Wagner M, Hawes S, Ebersole JS (2002) A standardized boundary element method volume conductor model. Clin Neurophysiol 113:702–712

    Article  PubMed  Google Scholar 

  • Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ, Mavrogiorgou P, Hegerl U (2000) The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 148:404–411

    Article  CAS  Google Scholar 

  • Garvey MJ, Noyes R Jr, Woodman C, Laukes C (1995) Relationship of generalized anxiety symptoms to urinary 5-hydroxyindoleacetic acid and vanillylmandelic acid. Psychiatry Res 57:1–5

    Article  CAS  PubMed  Google Scholar 

  • Germine M, Goddard AW, Woods SW, Charney DS, Heninger GR (1992) Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder. Biol Psychiatry 32:457–461

    Article  CAS  PubMed  Google Scholar 

  • Gorwood P (2004) Generalized anxiety disorder and major depressive disorder comorbidity: an example of genetic pleiotropy? Eur Psychiatry 19:27–33

    Article  CAS  PubMed  Google Scholar 

  • Gudlowski Y, Ozgürdal S, Witthaus H, Gallinat J, Hauser M, Winter C, Uhl I, Heinz A, Juckel G (2009) Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity. Schizophr Res 109:141–147

    Article  PubMed  Google Scholar 

  • Guille V, Croft RJ, O’Neill BV, Illic S, Phan KL, Nathan PJ (2008) An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Hum Psychopharmacol 23:231–241

    Article  CAS  PubMed  Google Scholar 

  • Handley SL (1995) 5-HT pathways in anxiety and its treatment. Pharmacol Ther 66:103–148

    Article  CAS  PubMed  Google Scholar 

  • Hegerl U, Juckel G (1993) Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33:173–187

    Article  CAS  PubMed  Google Scholar 

  • Hegerl U, Gallinat J, Juckel G (2001) Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62:93–100

    Article  CAS  PubMed  Google Scholar 

  • Hettema JM (2008) What is the genetic relationship between anxiety and depression? Am J Med Genet C Semin Med Genet 148C:140–146

    Article  PubMed  Google Scholar 

  • Iny LJ, Pecknold J, Suranyi-Cadotte BE, Bernier B, Luthe L, Nair NP, Meaney MJ (1994) Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets. Biol Psychiatry 36:281–291

    Article  CAS  PubMed  Google Scholar 

  • Juckel G, Molnár M, Hegerl U, Csépe V, Karmos G (1997) Auditory-evoked potentials as indicator of brain serotonergic activity—first evidence in behaving cats. Biol Psychiatry 41:1181–1195

    Article  CAS  PubMed  Google Scholar 

  • Juckel G, Hegerl U, Molnár M, Csépe V, Karmos G (1999) Auditory evoked potentials reflect serotonergic neuronal activity—a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 21:710–716

    Article  CAS  PubMed  Google Scholar 

  • Juckel G, Gallinat J, Riedel M, Sokullu S, Schulz C, Möller HJ, Müller N, Hegerl U (2003) Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 64:115–124

    Article  PubMed  Google Scholar 

  • Juckel G, Pogarell O, Augustin H, Mulert C, Müller-Siecheneder F, Frodl T, Mavrogiorgou P, Hegerl U (2007) Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry 68:1206–1212

    Article  PubMed  Google Scholar 

  • Juckel G, Hegerl U, Giegling I, Mavrogiorgou P, Wutzler A, Schuhmacher C, Uhl I, Brüne M, Mulert C, Pogarell O, Rujescu D (2008) Association of 5-HT1B receptor polymorphisms with the loudness dependence of auditory evoked potentials in a community-based sample of healthy volunteers. Am J Med Genet B Neuropsychiatr Genet 147B:454–458

    Article  PubMed  Google Scholar 

  • Kendler KS, Gardner CO, Gatz M, Pedersen NL (2007) The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol Med 37:453–462

    Article  PubMed  Google Scholar 

  • Linka T, Müller BW, Bender S, Sartory G (2004) The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression. Neurosci Lett 367:375–378

    Article  CAS  PubMed  Google Scholar 

  • Linka T, Sartory G, Bender S, Gastpar M, Müller BW (2007) The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls. An analysis of group differences. J Affect Disord 103:139–145

    Article  PubMed  Google Scholar 

  • Manjarrez G, Hernandez E, Robles A, Hernandez J (2005) N1/P2 component of auditory evoked potential reflect changes of the brain serotonin biosynthesis in rats. Nutr Neurosci 8:213–218

    Article  CAS  PubMed  Google Scholar 

  • Mulert C, Juckel G, Augustin H, Hegerl U (2002) Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. Clin Neurophysiol 113:1566–1572

    Article  CAS  PubMed  Google Scholar 

  • Nathan PJ, Segrave R, Phan KL, O’Neill B, Croft RJ (2006) Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 21:47–52

    Article  CAS  PubMed  Google Scholar 

  • Paige SR, Fitzpatrick DF, Kline JP, Balogh SE, Hendricks SE (1994) Event-related potential amplitude/intensity slopes predict response to antidepressants. Neuropsychobiology 30:197–201

    Article  CAS  PubMed  Google Scholar 

  • Paige SR, Hendricks SE, Fitzpatrick DF, Balogh S, Burke WJ (1995) Amplitude/intensity functions of auditory event-related potentials predict responsiveness to bupropion in major depressive disorder. Psychopharmacol Bull 31:243–248

    CAS  PubMed  Google Scholar 

  • Park YM, Lee SH, Kim S, Bae SM (2010) The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 34:313–316

    Article  PubMed  Google Scholar 

  • Pascual-Marqui RD (2002) Standardized low resolution brain electromagnetic tomography (sLORETA): technical details. Methods Find Exp Clin Pharmacol 24:5–12

    PubMed  Google Scholar 

  • Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, Mann JJ, Brunner D, Hen R (1998) Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci USA 95:14476–14481

    Article  CAS  PubMed  Google Scholar 

  • Semlitsch HV, Anderer P, Schuster P, Presslich O (1986) A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 23:695–703

    Article  CAS  PubMed  Google Scholar 

  • Senkowski D, Linden M, Zubrägel D, Bär T, Gallinat J (2003) Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Biol Psychiatry 53:304–314

    Article  CAS  PubMed  Google Scholar 

  • Sramek JJ, Tansman M, Suri A, Hornig-Rohan M, Amsterdam JD, Stahl SM, Weisler RH, Cutler NR (1996) Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms. J Clin Psychiatry 57:287–291

    CAS  PubMed  Google Scholar 

  • Strobel A, Debener S, Schmidt D, Hünnerkopf R, Lesch KP, Brocke B (2003) Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential. Am J Med Genet B Neuropsychiatr Genet 118B:41–47

    Article  CAS  PubMed  Google Scholar 

  • Taylor DP, Eison MS, Riblet LA, Vandermaelen CP (1985) Pharmacological and clinical effects of buspirone. Pharmacol Biochem Behav 23:687–694

    Article  CAS  PubMed  Google Scholar 

  • You JS, Hu SY, Chen B, Zhang HG (2005) Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder. Psychiatr Genet 15:7–11

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by an unrestricted educational grant from H. Lundbeck A/S, who were neither responsible for creation of the study protocol, the data analysis, data interpretation, nor writing of the manuscript. The authors thank Eung-Kyung Jo and Jeong-In Kim for their assistance with data collection.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seung-Hwan Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, YM., Kim, DW., Kim, S. et al. The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder. Psychopharmacology 213, 625–632 (2011). https://doi.org/10.1007/s00213-010-2061-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-010-2061-y

Keywords

Navigation